Barriers to Initiation of Antiretrovirals during Antituberculosis Therapy in Africa

• Dominique J. Pepper ,

  * E-mail: dominiquepepper@gmail.com

  Affiliation Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Suzaan Marais,

  Affiliations Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Infectious Diseases Unit, GF Jooste Hospital, Cape Town, South Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Robert J. Wilkinson,

  Affiliations Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Infectious Diseases Unit, GF Jooste Hospital, Cape Town, South Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa, Division of Medicine, Imperial College London, United Kingdom, MRC National Institute for Medical Research, Mill Hill, London, United Kingdom

  ⨯
• Feriyl Bhaijee,

  Affiliation Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Virginia De Azevedo,

  Affiliation City Health, Cape Town, South Africa

  ⨯
• Graeme Meintjes

  Affiliations Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Infectious Diseases Unit, GF Jooste Hospital, Cape Town, South Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa, Division of Medicine, Imperial College London, United Kingdom

  ⨯